| Quetiapine in Co-Morbid Depressive and Anxiety Disorders (NCT00688818) | Centre for Addiction and Mental Health | 2008-06-01 |
| TC-5214 as add-on the Treatment of Major Depressive Disorder (NCT00692445) | Targacept Inc. | 2008-06-01 |
| Using Neuroimaging to Investigate Major Depressive Disorder (NCT00781677) | University of Texas Southwestern Medical Center | 2008-05-01 |
| Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families (NCT00924976) | University of North Carolina, Chapel Hill | 2008-05-01 |
| Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD) (NCT00770289) | Pfizer | 2008-05-01 |
| Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults (NCT00694304) | H. Lundbeck A/S | 2008-05-01 |
| Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD) (NCT00705003) | Massachusetts General Hospital | 2008-05-01 |
| Brain Mechanisms and Targeting Insomnia in Major Depression (NCT00628914) | University of California, Los Angeles | 2008-05-01 |
| Exploring a Potential Blood Test to Diagnose Major Depressive Disorder (NCT00705185) | Massachusetts General Hospital | 2008-04-01 |
| Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder (NCT00672620) | Takeda | 2008-04-01 |
| Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms (NCT00578669) | Butler Hospital | 2008-04-01 |
| Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill (NCT00809770) | University of Washington | 2008-04-01 |
| Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder (NCT00672958) | Takeda | 2008-04-01 |
| Escitalopram in Adult Patients With Major Depressive Disorder (NCT00668525) | Forest Laboratories | 2008-04-01 |
| A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder (NCT00555997) | Massachusetts General Hospital | 2008-03-01 |
| Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) (NCT00683592) | Forest Laboratories | 2008-03-01 |
| Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder (NCT00659347) | DOV Pharmaceutical, Inc. | 2008-03-01 |
| Behavioral Insomnia Therapy For Those With Insomnia and Depression (NCT00620789) | Toronto Metropolitan University | 2008-03-01 |
| Combining Medications to Enhance Depression Outcomes (NCT00590863) | National Institute of Mental Health (NIMH) | 2008-03-01 |
| Tai Chi Training for Treating Depressed Chinese Americans (NCT01263730) | Massachusetts General Hospital | 2008-02-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder (NCT00619619) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-02-01 |
| Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder (NCT00635219) | H. Lundbeck A/S | 2008-02-01 |
| Transcranial Direct Current Stimulation (tDCS) in the Treatment of Major Depressive Disorder (MDD) (NCT01078948) | Centre for Addiction and Mental Health | 2008-02-01 |
| Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia (NCT00610259) | Nagoya City University | 2008-01-01 |
| Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety (NCT00621270) | BrainCells Inc. | 2008-01-01 |
| A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) (NCT00644358) | Forest Laboratories | 2007-12-31 |
| A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression (NCT00566202) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-12-01 |
| Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes (NCT00596817) | H. Lundbeck A/S | 2007-12-01 |
| Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device (NCT00578383) | Mclean Hospital | 2007-11-01 |
| Do Antidepressants Induce Metabolic Syndromes METADAP Study (NCT00526383) | Assistance Publique - Hôpitaux de Paris | 2007-11-01 |
| Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months (NCT00561509) | Eli Lilly and Company | 2007-11-01 |
| Continuation Ketamine in Major Depression (NCT00548964) | James Murrough | 2007-10-01 |
| Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression (NCT00521352) | New York State Psychiatric Institute | 2007-10-01 |
| Dose-finding Study With Lu AA24530 in Major Depressive Disorder (NCT00599911) | H. Lundbeck A/S | 2007-10-01 |
| Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression (NCT00518986) | Cephalon | 2007-10-01 |
| An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder (NCT00531622) | Sanofi | 2007-09-01 |
| A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients (NCT00536471) | Eli Lilly and Company | 2007-09-01 |
| Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response. (NCT00421369) | Hadassah Medical Organization | 2007-09-01 |
| Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder (NCT00529789) | Eli Lilly and Company | 2007-08-01 |
| Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder (NCT00511810) | University of Cincinnati | 2007-08-01 |
| Does Dual Therapy Hasten Antidepressant Response? (NCT00519428) | New York State Psychiatric Institute | 2007-08-01 |
| Project to Improve Symptoms and Mood in People With Spinal Cord Injury (NCT00592384) | University of Washington | 2007-07-01 |
| Duloxetine for the Treatment of Postpartum Depression (NCT00617045) | Yale University | 2007-07-01 |
| Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression (NCT00531947) | Somerset Pharmaceuticals | 2007-07-01 |
| Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder (NCT00514865) | Ono Pharma USA Inc | 2007-06-13 |
| Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide (NCT00400088) | Nova Scotia Health Authority | 2007-06-01 |
| Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults (NCT00761306) | H. Lundbeck A/S | 2007-06-01 |
| Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression (NCT00723970) | McMaster University | 2007-06-01 |
| A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder. (NCT00775203) | Labopharm Inc. | 2007-06-01 |
| A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia (NCT00435279) | Sumitomo Pharma America, Inc. | 2007-06-01 |
| Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults (NCT00696293) | University of Pittsburgh | 2007-05-01 |
| A Controlled Study to Assess the Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients With Major Depressive Disorder (NCT00464048) | Hadassah Medical Organization | 2007-05-01 |
| Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon (NCT00642694) | University of Texas Southwestern Medical Center | 2007-05-01 |
| Pilot Study of Duloxetine in Psychological Resilience (NCT00331799) | Duke University | 2007-04-01 |
| Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients (NCT00474708) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-04-01 |
| Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder (NCT00467402) | Novartis | 2007-04-01 |
| Psychosocial Treatment of Depression in Parkinson's Disease (NCT00853346) | Amy Farabaugh, PhD | 2007-04-01 |
| Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression (NCT00873795) | Chimei Medical Center | 2007-04-01 |
| Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease (NCT00437125) | Eli Lilly and Company | 2007-03-01 |
| Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors (NCT00433238) | Mount Sinai Hospital, Canada | 2007-03-01 |
| Pharmacogenomics Studies of Antidepressants (NCT01204086) | National Cheng-Kung University Hospital | 2007-03-01 |
| Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism (NCT00452543) | Massachusetts General Hospital | 2007-03-01 |
| A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD) (NCT00463242) | Novartis | 2007-03-01 |
| Early Prediction of Fluoxetine Response (NCT01075529) | Kaohsiung Kai-Suan Psychiatric Hospital | 2007-03-01 |
| A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression (NCT00402220) | Bayside Health | 2007-03-01 |
| A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression (NCT00422162) | Eli Lilly and Company | 2007-02-01 |
| Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder (NCT00442481) | Sheba Medical Center | 2007-02-01 |
| Duloxetine for Perimenopausal Depression (NCT00517985) | University of Arizona | 2007-02-01 |
| D-cycloserine for Major Depressive Disorder (NCT00408031) | Herzog Hospital | 2007-01-01 |
| Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder (NCT00432614) | Sanofi | 2007-01-01 |
| Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled Study (NCT02383693) | Centre hospitalier de Ville-Evrard, France | 2007-01-01 |
| Focal Electroconvulsive Therapy for Depression (NCT01589315) | Medical University of South Carolina | 2007-01-01 |
| Creatine as a New Therapeutic Strategy in Depression (NCT00313417) | Herzog Hospital | 2007-01-01 |
| A Study for Participants With Major Depression (NCT00420004) | Eli Lilly and Company | 2006-12-01 |
| Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder (NCT01606384) | Sanofi | 2006-12-01 |
| Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder (NCT00411099) | Novartis | 2006-12-01 |
| A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD) (NCT00321152) | Massachusetts General Hospital | 2006-11-01 |
| A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients (NCT00406848) | Eli Lilly and Company | 2006-11-01 |
| Evaluation of the Effects of Duloxetine on Norepinephrine (NCT00414323) | Eli Lilly and Company | 2006-11-01 |
| Study of Adolescence and Depression (NCT00523081) | Kaiser Permanente | 2006-10-01 |
| A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence (NCT00377299) | University of Texas Southwestern Medical Center | 2006-10-01 |
| Brain Imaging of Psychotherapy for Depression (NCT00609453) | University of North Carolina, Chapel Hill | 2006-10-01 |
| Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents (NCT00353028) | Solvay Pharmaceuticals | 2006-10-01 |
| Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients (NCT00384436) | Forest Laboratories | 2006-10-01 |
| Brain GABA Levels and Treatment Response in Major Depressive Disorder (NCT00464711) | Massachusetts General Hospital | 2006-09-01 |
| STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse (NCT00369746) | New York State Psychiatric Institute | 2006-09-01 |
| Deep Brain Stimulation for Treatment Resistant Depression (NCT00367003) | Emory University | 2006-09-01 |
| Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder (NCT00388973) | AstraZeneca | 2006-09-01 |
| Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home (NCT00505518) | Massachusetts General Hospital | 2006-09-01 |
| Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness (NCT02334228) | Dartmouth-Hitchcock Medical Center | 2006-09-01 |
| Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS) (NCT00385307) | Sanofi | 2006-09-01 |
| Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients (NCT00369798) | National Institute of Mental Health (NIMH) | 2006-08-02 |
| Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults (NCT00839423) | H. Lundbeck A/S | 2006-08-01 |
| Imaging Predictors of Treatment Response in Depression (NCT00367341) | Emory University | 2006-08-01 |
| Treatment of Mood and Marriage Study (TOMMS) (NCT00612807) | Duke University | 2006-07-01 |
| Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression (NCT00361374) | Massachusetts General Hospital | 2006-07-01 |
| Dichotic Listening as a Predictor of Medication Response in Depression (NCT00404755) | New York State Psychiatric Institute | 2006-07-01 |
| Genetic Study of Liver Enzymes in Patients With Side Effects From Antidepressants (NCT00360256) | Augusta University | 2006-06-01 |
| Changes in Cerebral Glucose Metabolism After Electroconvulsive Therapy (ECT) (NCT01514435) | Medical University of Graz | 2006-05-01 |
| Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder (NCT00351910) | AstraZeneca | 2006-05-01 |